Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

VCYT

VERACYTE, INC.

Services-Medical Laboratories · SIC 8071CIK 1384101Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.52B
Net Income FY2025
$0.07B
EPS (Basic, as reported)
$0.84
Net Margin FY2025
12.8%
ROE FY2025
5.1%
Total Equity
$1.31B
Shares Out
80M
Business description

VERACYTE, INC. — Services-Medical Laboratories. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 65 → 517 +25.9% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue657292120117220297361446517
Cost of revenue(25)(28)(33)(36)——————
Gross profit——————176230298363
Research & development(15)(14)(15)(15)(17)(30)(41)(57)(69)(71)
Selling & marketing(28)(32)(41)(54)(52)(80)(98)(101)(95)(100)
General & administrative(24)(23)(24)(29)(37)(101)(77)(86)(111)(111)
Total operating expenses(94)(98)(114)(135)(153)(301)(338)(447)(282)(305)
Operating income(29)(27)(22)(15)(35)(82)(41)(86)1658
Interest expense(3)(5)(2)(1)0—————
Interest & investment income——————————
Other income (expense), net001310591010
Pre-tax income(31)(31)(23)(12)(35)(82)(36)(77)2668
Income tax expense00000(6)0(2)(2)(2)
Net income(31)(31)(23)(13)(35)(76)(37)(74)2466
EPS — basic———($0.27)($0.66)($1.11)($0.51)($1.02)$0.32$0.84
EPS — diluted———($0.27)($0.66)($1.11)($0.51)($1.02)$0.31$0.82
Shares outstanding — basic (M)———46536872737679
Shares outstanding — diluted (M)———46536872737881

Showing the latest 10 of 15 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.